Abera Bioscience AB (8WK) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	4.92M	-939.00K	3.55M	1.56M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.70M	7.85M	9.30M	7.11M
Operating expense	5.79M	7.96M	9.39M	7.19M
Total operating expenses	5.79M	7.96M	9.39M	7.19M
Operating income	-867.00K	-8.90M	-5.83M	-5.63M
Other non operating income	-2.00K	1.00K	-	1.00K
EBT including unusual items	-835.00K	-8.80M	-5.80M	-5.56M
EBT excluding unusual items	-835.00K	-8.80M	-5.80M	-5.56M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	42.00K	49.00K	25.00K	15.00K
Net income	-835.00K	-8.80M	-5.80M	-5.56M
Net profit margin	-16.97%	936.85%	-163.13%	-355.66%
Earnings per share	-	-	-	-
Interest and investment income	34.00K	69.00K	40.00K	67.00K
Interest expense	-	-	-2.00K	-
Net interest expenses	34.00K	69.00K	38.00K	67.00K
Depreciation and amortization charges	45.00K	62.00K	63.00K	63.00K
EBITDA	-822.00K	-8.84M	-5.77M	-5.56M
Gain or loss from assets sale	-	-	-	-

Finance